创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology ELISA Platform: Opening a New Era of Efficient and Accurate Biological Detection

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-06-26 16:07
  • Views:

(Summary description)In the field of biotechnology, enzyme-linked immunosorbent assay (ELISA), as a highly efficient assay, plays a crucial role in the observation of reactivity between biologically active ligands. However, the results of ELISA assay are affected by various factors, such as sensitivity, specificity, precision and stability. In order to provide a more reliable and efficient ELISA service, InnoModels Biotechnology has developed an ELISA platform, which has demonstrated significant value in the field of scientific research and clinical diagnostics due to its unique advantages.

InnoModels Biotechnology ELISA Platform: Opening a New Era of Efficient and Accurate Biological Detection

(Summary description)In the field of biotechnology, enzyme-linked immunosorbent assay (ELISA), as a highly efficient assay, plays a crucial role in the observation of reactivity between biologically active ligands. However, the results of ELISA assay are affected by various factors, such as sensitivity, specificity, precision and stability. In order to provide a more reliable and efficient ELISA service, InnoModels Biotechnology has developed an ELISA platform, which has demonstrated significant value in the field of scientific research and clinical diagnostics due to its unique advantages.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-06-26 16:07
  • Views:
Information

In the field of biotechnology, enzyme-linked immunosorbent assay (ELISA), as a highly efficient assay, plays a crucial role in the observation of reactivity between biologically active ligands. However, the results of ELISA assay are affected by various factors, such as sensitivity, specificity, precision and stability. In order to provide a more reliable and efficient ELISA service, InnoModels Biotechnology has developed an ELISA platform, which has demonstrated significant value in the field of scientific research and clinical diagnostics due to its unique advantages.
1、Advanced platform technology
InnoModels Bio's ELISA platform adopts a series of advanced biotechnology and detection methods to ensure the accuracy and reliability of the experimental results. The kits on the platform are based on unique monoclonal antibody technology, which can provide strong support for the specificity, sensitivity and batch-to-batch consistency of ELISA assays. In addition, the platform adopts advanced signal amplification technology and data analysis system to further improve the sensitivity and accuracy of the assay.
2. Strict quality control
InnoModels Biotechnology has strict quality control of ELISA platform. From the procurement of raw materials to the delivery of finished products, each step is subject to strict quality inspection and monitoring. In addition, the platform has established a perfect quality management system to ensure that each batch of kits meets the predetermined quality standards. This strict quality control makes InnoModels' ELISA platform stand out among similar products and win wide recognition.

 


3、Abundant Product Variety
InnoModels Bio's ELISA platform provides a rich and diverse product assortment, covering a wide range of reactive species such as human, rat, mouse, pig and so on. A wide range of kits are available on the platform, including cytokines, hormones, tumor markers, autoimmune disease detection and many other areas. These kits can meet the needs of different research fields and provide comprehensive technical support for researchers.
4、Customized service
InnoModels Biotechnology attaches great importance to the needs of customers and provides personalized customized services. Customers can choose the types and specifications of kits suitable for them according to their own research needs. In addition, the platform also provides exclusive customization services, including the development and production of customized kits for different diseases. This flexible service model enables the ELISA platform of InnoModels Biotechnology to better meet the needs of customers.
5、Professional technical support
InnoModels Biotechnology has a professional technical team with rich experience and expertise in ELISA testing. The team members are able to provide comprehensive technical support and solutions to help customers solve problems encountered during the experimental process. In addition, the platform also provides detailed experimental guidance and operation manuals to help customers better use the kits for experiments.
In conclusion, with its advantages of advanced technology, strict quality control, rich product range, customized services and professional technical support, the ELISA platform of InnoModels Biotechnology has demonstrated significant value in the field of scientific research and clinical diagnosis. In the future, with the continuous development and innovation of biotechnology, InnoModels' ELISA platform will continue to play an important role and make greater contributions to human health and life science research.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司